Elanco Animal Health (ELAN) Tops Q2 EPS by 6c ; Offers Guidance

Elanco Animal Health (NYSE: ELAN) reported Q2 EPS of $0.26, $0.06 better than the analyst estimate of $0.20. Revenue for the quarter came in at $1.24 billion versus the consensus estimate of $1.18 billion.

GUIDANCE:

Elanco Animal Health sees FY2025 EPS of $0.85-$0.91, versus the consensus of $0.84. Elanco Animal Health sees FY2025 revenue of $4.57-4.62 billion, versus the consensus of $4.54 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.

You May Also Be Interested In

• Saudi Arabia cut the price of its main crude grade for customers in Asia in August - Bloomberg
• UBS Reiterates Sell Rating on National Beverage (FIZZ) Following Q4 Results
• Solstice acquiring Element Solutions in $14.5B cash and stock deal